.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,340,849

« Back to Dashboard

Details for Patent: 5,340,849

Title: Biodegradable in-situ forming implants and methods for producing the same
Abstract:A biodegradable polymer is provided for use in providing syringeable, in-situ forming, solid biodegradable implants for animals. The polymer is placed into the animal in liquid form and cures to form the implant in-situ. A thermoplastic system to form said implant comprises the steps of dissolving a non-reactive polymer in biocompatible solvent to form a liquid, placing the liquid within the animal, and allowing the solvent to dissipate to produce the implant. An alternative, thermosetting system comprises mixing together effective amounts of a liquid acrylic ester terminated, biodegradable prepolymer and a curing agent, placing the liquid mixture within an animal and allowing the prepolymer to cure to form the implant. Both systems provide a syringeable, solid biodegradable delivery system by the addition of an effective level of biologically active agent to the liquid before injection into the body.
Inventor(s): Dunn; Richard L. (Fort Collins, CO), English; James P. (Birmingham, AL), Cowsar; Donald R. (Birmingham, AL), Vanderbilt; David D. (Birmingham, AL)
Assignee: Atrix Laboratories, Inc. (Fort Collins, CO)
Filing Date:Dec 23, 1991
Application Number:07/788,032
Claims:1. A method of forming a solid implant in-situ within a living body, comprising the steps of:

a) mixing together effective amounts of a liquid acrylic-ester-terminated, biodegradable prepolymer of terminal acryloyl groups and a residue of an oligomer having terminal functional groups which react with acryloyl acylating groups and a curing agent to form a mixture in a liquid form; and

b) delivering said mixture within said body while said mixture is in a liquid form so as to allow said prepolymer to cure to form said solid implant.

2. The method of claim 1, and further comprising the step of forming said liquid acrylic-ester-terminated biodegradable prepolymer by converting a polyol-terminated biodegradable prepolymer.

3. The method of claim 2, and further comprising the step of forming said polyol-terminated biodegradable prepolymer by copolymerization of DL-lactide and .epsilon.-caprolactone with a polyol initiator.

4. The method of claim 3, and further comprising the step of adding a catalyst to said copolymerization step.

5. The method of claim 4, wherein said catalyst is stannous octcate.

6. The method of claim 4, wherein said catalyst is stannous chloride.

7. The method of claim 2, and further comprising the step of forming said polyol-terminated biodegradable prepolymer by copolymerization of L-lactide and .epsilon.-caprolactone with a polyol initiator.

8. The method of claim 7, and further comprising the step of adding a catalyst to said copolymerization step.

9. The method of claim 8, wherein said catalyst is stannous octoate.

10. The method of claim 8, wherein said catalyst is stannous chloride.

11. The method of claim 1, wherein said curing agent is azobisisobutyronitrile.

12. The method of claim 1, wherein said curing agent is benzoyl peroxide.

13. The method of claim 1, and further comprising the step of adding a biologically active agent to said biodegradable prepolymer and curing agent mixture to provide, upon curing, a biodegradable implant which releases said biologically active agent by diffusion or erosion as said implant biodegrades.

14. The method of claim 1, wherein said delivering step comprises injecting said mixture into said body by means of a syringe and needle.

15. A biodegradable implant for a body produced according to the method of claim 1.

16. A method of forming a solid biodegradable implant in-situ in a living body, comprising the step of injecting mixture within said body, wherein said liquid comprises effective amounts of a liquid acrylic-ester-terminated biodegradable prepolymer of terminal acryloyl groups and a residue of an oligomer having terminal functional groups which react with acryloyl acylating groups and a curing agent.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc